HYBRID CHOLECYSTOKININ (CCK) ANTAGONISTS - NEW IMPLICATIONS IN THE DESIGN AND MODIFICATION OF CCK ANTAGONISTS

被引:37
作者
KERWIN, JF
NADZAN, AM
KOPECKA, H
LIN, CW
MILLER, T
WITTE, D
BURT, S
机构
关键词
D O I
10.1021/jm00124a003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:739 / 742
页数:4
相关论文
共 17 条
[1]  
BRITTON DR, UNPUB PHARM BIOCH BE
[3]   STRUCTURE, ENERGETICS AND DYNAMICS OF LIGAND-BINDING TO DIHYDROFOLATE-REDUCTASE [J].
DAUBER, P ;
OSGUTHORPE, DJ ;
HAGLER, AT .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1982, 10 (05) :312-318
[4]   DESIGN OF POTENT, ORALLY EFFECTIVE, NONPEPTIDAL ANTAGONISTS OF THE PEPTIDE-HORMONE CHOLECYSTOKININ [J].
EVANS, BE ;
BOCK, MG ;
RITTLE, KE ;
DIPARDO, RM ;
WHITTER, WL ;
VEBER, DF ;
ANDERSON, PS ;
FREIDINGER, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4918-4922
[5]  
FREIDINGER RM, 1987, Patent No. 3050884
[6]  
HILL DR, 1987, J NEUROSCI, V7, P2967
[7]   DISTINCT CHOLECYSTOKININ RECEPTORS IN BRAIN AND PANCREAS [J].
INNIS, RB ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (11) :6917-6921
[8]  
LIN CW, 1986, J PHARMACOL EXP THER, V236, P729
[9]  
MAKOVEC F, 1986, ARZNEIMITTEL-FORSCH, V36-1, P98
[10]  
MAKOVEC F, 1985, ARZNEIMITTELFORSCH, V35-2, P1048